Pfizer’s bivalent vaccine, strong antibody response one month after vaccination | Reuters

(Correct typos and resend)

[４日 ロイター] – On the 4th, US pharmaceutical Pfizer and Germany’s Biontech jointly developed a bivalent vaccine for the Omicron strain derivative “BA.4” and “BA.5” of the new coronavirus, and a strong antibody response was shown one month after vaccination. announced.

Based on the data presented by the two companies, about 36 people aged 55 and over showed that neutralizing antibody levels against “BA.4” and “BA.5” increased by about four times one month after booster (additional) administration of the bivalent vaccine. It was shown that